Orbital lesions, an exceedingly rare site of neuroendocrine tumor metastasis

Sara Pusceddu , Massimo Milione , Silvia Ortolani , Alessio Pellegrinelli , Marco Brugia , Filippo de Braud , Lorenzo Antonuzzo

Journal of Cancer Metastasis and Treatment ›› 2016, Vol. 2 : 341 -4.

PDF
Journal of Cancer Metastasis and Treatment ›› 2016, Vol. 2:341 -4. DOI: 10.20517/2394-4722.2016.41
Case Report
review-article

Orbital lesions, an exceedingly rare site of neuroendocrine tumor metastasis

Author information +
History +
PDF

Abstract

Neuroendocrine tumors are rare neoplasms arising primarily in the gastrointestinal tract and lung. The liver is the most common site of metastases, but these tumors can rarely metastasize to atypical sites. Surgery is the only curative approach while the optimal medical treatment is debated. From this perspective, a multidisciplinary approach for each single case becomes very important. In this report we describe the case of a male affected by a single intraorbital metastasis from a midgut well differentiated neuroendocrine tumor. The patient refused surgical removal and therefore he was at first treated with stereotactic radiotherapy and systemic treatment with a somatostatin analog (SSA). After achieving a stable disease for four months he underwent primary tumor resection. Six years after the initial diagnosis, the patient is currently stable and receiving SSA at standard dose.

Keywords

Neuroendocrine tumors / orbital metastases / somatostatin analogues

Cite this article

Download citation ▾
Sara Pusceddu, Massimo Milione, Silvia Ortolani, Alessio Pellegrinelli, Marco Brugia, Filippo de Braud, Lorenzo Antonuzzo. Orbital lesions, an exceedingly rare site of neuroendocrine tumor metastasis. Journal of Cancer Metastasis and Treatment, 2016, 2: 341-4 DOI:10.20517/2394-4722.2016.41

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Modlin IM,Kidd M.A 5-decade analysis of 13,715 carcinoid tumors..Cancer2003;97:934-59

[2]

Pinchot SN,Sippel RS.Carcinoid tumors..Oncologist2008;13:1255-69 PMCID:PMC2901509

[3]

Zuetenhorst JM.Metastatic carcinoid tumors: a clinical review..Oncologist2005;10:123-31

[4]

Karcioglu ZA.Orbital tumours: Diagnosis and treatment..2nd ed.2005;New YorkSpringer187-9

[5]

Peixoto RD,Cheung WY.Neuroendocrine tumor metastatic to the orbit treated with radiotherapy..World J Gastrointest Oncol2013;5:177-80 PMCID:PMC3761178

[6]

Mehta JS,Rose GE.Orbital carcinoid metastases..Ophthalmology2006;113:466-72

[7]

Borota OC,Lindal S.Carcinoid tumour metastatic to the orbit with infiltration to the extraocular orbital muscle..APMIS2005;113:135-9

[8]

Modlin IM,Kidd M.Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours..Aliment Pharmacol Ther2010;31:169-88

[9]

Rinke A,Schade-brittinger C,Barth P,Mayer C,Pape UF,Harder J,Gress T.Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors..J Clin Oncol2009;27:4656-63

[10]

Caplin ME,Ćwikła JB,Raderer M,Cadiot G,Capdevila J,Rindi G,Martinez S,Ruszniewski P.Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors..N Engl J Med2014;371:224-33

AI Summary AI Mindmap
PDF

19

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/